Collectively, these findings indicate that SESN2 enhances autophagy in prostate cancer cells by modulating key autophagy regulators, including ULK, LC3B, and p62, ultimately promoting autophagic activity. This evidence concerns the gene MAP1LC3B and prostate carcinoma.